Rosetta Omics

๐Ÿ“ Paris, France๐Ÿ—“ Founded 2022๐Ÿ‘ฅ 9 employees
Worldwide, there are more than 20 million new cases of cancer each year. First-line therapies are not always the most effective and there is a strong need to move towards personalized medicine by offering the patients the best treatment as quickly as possible. This will help in increasing the chance or cure. Therefore, there is a need to improve the prediction of the response to treatments to be able to save patientโ€™s lives and reduce the cost of expensive inefficient treatments. Our goal is to unlock the road to precision medicine by using multiomics, spatial data and AI.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Rosetta Omics founded?
Rosetta Omics was founded in 2022.
What industry is Rosetta Omics in?
Rosetta Omics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Rosetta Omics based?
Rosetta Omics is headquartered in Paris, France.